Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India—Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity

PLoS Neglected Tropical Diseases

Volumn 10, Issue 3, 2016, Pages

  Singla, Mohit ^a   Kar, Meenakshi ^b   Sethi, Tavpritesh ^c   Kabra, Sushil K ^a   Lodha, Rakesh ^a   Chandele, Anmol ^d   Medigeshi, Guruprasad R ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE   (India)

^c CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD14 ANTIGEN; CD16 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTRINSIC FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTRUCTURAL PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

ARTICLE; BLEEDING; CELL ISOLATION; CHILD; CONTROLLED STUDY; DENGUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE SEQUENCE; HUMAN; IMMUNE RESPONSE; INDIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RESPIRATORY DISTRESS; SCHOOL CHILD; THROMBOCYTOPENIA; VIREMIA; VIRUS PATHOGENESIS; BLOOD; CHEMISTRY; COHORT ANALYSIS; DENGUE VIRUS; IMMUNOLOGY; IMMUNOPHENOTYPING; MONOCYTE; PATHOLOGY; PRESCHOOL CHILD; VIROLOGY;

ANTIGENS, CD14; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOKINES; DENGUE; DENGUE VIRUS; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNOPHENOTYPING; INDIA; MALE; MONOCYTES; RECEPTORS, IGG; VIREMIA;

EID: 84962425384     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004497     Document Type: Article

References (58)

1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature496: 504–507. doi: 10.1038/nature1206023563266
2. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM, (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis10: 712–722. doi: 10.1016/S1473-3099(10)70166-320883967
3. Libraty DH, Acosta LP, Tallo V, Segubre-Mercado E, Bautista A, et al. (2009) A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. PLoS Med6: e1000171. doi: 10.1371/journal.pmed.100017119859541
4. Rothman AL, (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol11: 532–543. doi: 10.1038/nri301421760609
5. Tang WW, Grewal R, Shresta S, (2015) Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models. Current Opinion in Virology13: 61–66. doi: 10.1016/j.coviro.2015.04.00726001278
6. Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, et al. (2007) Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet369: 1452–1459. 17467515
7. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, et al. (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis8: 86. doi: 10.1186/1471-2334-8-8618578883
8. Hatch S, Endy TP, Thomas S, Mathew A, Potts J, et al. (2011) Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J Infect Dis203: 1282–1291. doi: 10.1093/infdis/jir01221335561
9. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, et al. (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis185: 1213–1221. 12001037
10. Rathakrishnan A, Klekamp B, Wang SM, Komarasamy TV, Natkunam SK, et al. (2014) Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in Malaysia. PLoS One9: e92021. doi: 10.1371/journal.pone.009202124647042
11. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity. Journal of Infectious Diseases181: 2–9. 10608744
12. Organization WH (2009) Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. Geneva.
13. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, et al. (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis189: 221–232. 14722886
14. Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, et al. (1999) Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. The American Journal of Tropical Medicine and Hygiene60: 693–698. 10348250
15. Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, et al. (2006) Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunol Med Microbiol48: 84–90. 16965355
16. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV, (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol30: 545–551. 1372617
17. Agrawal T, Schu P, Medigeshi GR, (2013) Adaptor protein complexes-1 and 3 are involved at distinct stages of flavivirus life-cycle. Sci Rep3: 1813. doi: 10.1038/srep0181323657274
18. Breiman L, (2001) Random Forests. Machine Learning45: 5–32.
19. Kursa MB, Rudnicki WR, (2010) Feature Selection with the Boruta Package. Journal of Statistical Software36: 1–13.
20. Kursa MB, (2014) Robustness of Random Forest-based gene selection methods. BMC Bioinformatics15: 8. doi: 10.1186/1471-2105-15-824410865
21. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, et al. (2004) Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis189: 990–1000. 14999601
22. Fox A, Hoa LNM, Simmons CP, Wolbers M, Wertheim HFL, et al. (2011) Immunological and Viral Determinants of Dengue Severity in Hospitalized Adults in Ha Noi, Viet Nam. PLoS Negl Trop Dis5: e967. doi: 10.1371/journal.pntd.000096721390156
23. Wang W-K, Chao D-Y, Kao C-L, Wu H-C, Liu Y-C, et al. (2003) High Levels of Plasma Dengue Viral Load during Defervescence in Patients with Dengue Hemorrhagic Fever: Implications for Pathogenesis. Virology305: 330–338. 12573578
24. Wang W-K, Chen H-L, Yang C-F, Hsieh S-C, Juan C-C, et al. (2006) Slower Rates of Clearance of Viral Load and Virus-Containing Immune Complexes in Patients with Dengue Hemorrhagic Fever. Clinical Infectious Diseases43: 1023–1030. 16983615
25. Hottz ED, Oliveira MF, Nunes PC, Nogueira RM, Valls-de-Souza R, et al. (2013) Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost11: 951–962. doi: 10.1111/jth.1217823433144
26. Noisakran S, Onlamoon N, Hsiao HM, Clark KB, Villinger F, et al. (2012) Infection of bone marrow cells by dengue virus in vivo. Exp Hematol40: 250–259 e254. doi: 10.1016/j.exphem.2011.11.01122193689
27. Sridharan A, Chen Q, Tang KF, Ooi EE, Hibberd ML, et al. (2013) Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice. J Virol87: 11648–11658. doi: 10.1128/JVI.01156-1323966397
28. Pang T, Cardosa MJ, Guzman MG, (2007) Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol85: 43–45. 17130899
29. Durbin AP, Vargas MJ, Wanionek K, Hammond SN, Gordon A, et al. (2008) Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology376: 429–435. doi: 10.1016/j.virol.2008.03.02818452966
30. Lin YW, Wang KJ, Lei HY, Lin YS, Yeh TM, et al. (2002) Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol76: 12242–12249. 12414963
31. Schmid MA, Harris E, (2014) Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication. PLoS Pathog10: e1004541. doi: 10.1371/journal.ppat.100454125474197
32. Shepard DS, Halasa YA, Tyagi BK, Adhish SV, Nandan D, et al. (2014) Economic and disease burden of dengue illness in India. Am J Trop Med Hyg91: 1235–1242. doi: 10.4269/ajtmh.14-000225294616
33. Chen RF, Liu JW, Yeh WT, Wang L, Chang JC, et al. (2005) Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol44: 43–50. 15780577
34. Ngwe Tun MM, Thant KZ, Inoue S, Kurosawa Y, Lwin YY, et al. (2013) Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar. J Med Virol85: 1258–1266. doi: 10.1002/jmv.2357723595687
35. Murgue B, Roche C, Chungue E, Deparis X, (2000) Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996–1997 dengue-2 outbreak in French Polynesia. J Med Virol60: 432–438. 10686027
36. Sudiro TM, Zivny J, Ishiko H, Green S, Vaughn DW, et al. (2001) Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol63: 29–34. 11130884
37. Balmaseda A, Hammond SN, Perez L, Tellez Y, Saborio SI, et al. (2006) Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg74: 449–456. 16525106
38. Tang Y, Kou Z, Zhang F, Yao X, Liu S, et al. (2010) Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One5: e15631. doi: 10.1371/journal.pone.001563121206915
39. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS, (2000) Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol28: 183–188. 10865168
40. Mangione JN, Huy NT, Lan NT, Mbanefo EC, Ha TT, et al. (2014) The association of cytokines with severe dengue in children. Trop Med Health42: 137–144. doi: 10.2149/tmh.2014-0925589878
41. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, et al. (2010) Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One5: e8709. doi: 10.1371/journal.pone.000870920090849
42. Raghupathy R, Chaturvedi UC, Al-Sayer H, Elbishbishi EA, Agarwal R, et al. (1998) Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol56: 280–285. 9783699
43. Suharti C, van Gorp EC, Dolmans WM, Setiati TE, Hack CE, et al. (2003) Cytokine patterns during dengue shock syndrome. Eur Cytokine Netw14: 172–177. 14656693
44. Seder RA, Gazzinelli R, Sher A, Paul WE, (1993) Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proceedings of the National Academy of Sciences90: 10188–10192.
45. Malavige GN, Gomes L, Alles L, Chang T, Salimi M, et al. (2013) Serum IL-10 as a marker of severe dengue infection. BMC Infect Dis13: 341. doi: 10.1186/1471-2334-13-34123883139
46. Malavige GN, Jeewandara C, Alles KM, Salimi M, Gomes L, et al. (2013) Suppression of virus specific immune responses by IL-10 in acute dengue infection. PLoS Negl Trop Dis7: e2409. doi: 10.1371/journal.pntd.000240924040431
47. Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, et al. (2004) IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol73: 230–234. 15122797
48. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. (1999) Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. Journal of Medical Virology59: 329–334. 10502265
49. Rolph MS, Zaid A, Rulli NE, Mahalingam S, (2011) Downregulation of Interferon-β in Antibody-Dependent Enhancement of Dengue Viral Infections of Human Macrophages Is Dependent on Interleukin-6. Journal of Infectious Diseases204: 489–491. doi: 10.1093/infdis/jir27121742851
50. Pagliari C, Quaresma JA, Fernandes ER, Stegun FW, Brasil RA, et al. (2014) Immunopathogenesis of dengue hemorrhagic fever: contribution to the study of human liver lesions. J Med Virol86: 1193–1197. doi: 10.1002/jmv.2375824114877
51. Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, et al. (2005) Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol174: 395–403. 15611263
52. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I, (2004) IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol85: 1801–1813. 15218164
53. Carrette F, Surh CD, (2012) IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin Immunol24: 209–217. doi: 10.1016/j.smim.2012.04.01022551764
54. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR, (2002) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation106: 896–899. 12186789
55. Viallard JF, Solanilla A, Gauthier B, Contin C, Dechanet J, et al. (2002) Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood99: 2612–2614. 11895803
56. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, et al. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat Med12: 1301–1309. 17041596
57. Couper KN, Blount DG, Riley EM, (2008) IL-10: the master regulator of immunity to infection. J Immunol180: 5771–5777. 18424693
58. Kwissa M, Nakaya HI, Onlamoon N, Wrammert J, Villinger F, et al. (2014) Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe16: 115–127. doi: 10.1016/j.chom.2014.06.00124981333